DEXTROSE INJECTION,

The Defense Logistics Agency awarded a single-line-item delivery order under the basic contract SPE2DX-25-D-8022 to Cardinal Health, Inc. (CAGE 00E55) for the supply of 1.000 PG of DEXTROSE INJECTION (NSN 6505013318941, manufacturer part 00264751020) at a total contract price of $83.48. The delivery is scheduled for July 14, 2026, with FOB destination terms, meaning the contractor assumes all transportation costs and risks until receipt at the designated military facility in San Diego, California. The order carries zero variance allowance, requiring exact compliance with the specified quantity, and permits medical substitution under the established rank configuration. Packaging and marking must adhere to contract identification requirements using Block 1 and Block 2 data, with parcel post expressly prohibited and delivery restricted to the fastest traceable means. Inspection and acceptance occur at the destination by government personnel, and invoicing must be submitted electronically via EDI, likely through the Wide Area Workflow system. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, using the provided accounting and appropriation data. Cardinal Health, Inc. is certified as a small business, small disadvantaged business, and women-owned small business, triggering associated socioeconomic reporting obligations. The contract vehicle is structured as an IDIQ, with this delivery order issued under existing master terms. No explicit contract clauses, legal citations, packaging standards like MIL-STD-129 or MIL-STD-2073, or special requirements beyond shipment, marking, substitution, and payment terms are documented in the available text. The award was made on a lowest price technically acceptable basis, with no non-price evaluation factors disclosed.